SA国际传媒

Sunday 27 September 2026
Salisbury Foundation Trust

FOI_9563

Internal Reference Number: FOI_9563

Date Request Received: 21/07/2026 00:00:00

Date Request Replied To: 31/07/2026 00:00:00

This response was sent via: By Email

Request Summary: Oncology 鈥� Myelofibrosis and SCT

Request Category: Researcher




 
Question Number 1:
How many patients were initiated on Ruxolitinib (Jakavi) in the past 6 months for the following conditions? (Patients are classed as initiated if they have not received any of the above treatments in the previous 6 months)

鈥� Myelofibrosis (ICD10 code D47.4)

鈥� Polycythaemia Vera (ICD10 code D45)

鈥� Graft vs Host Disease (GvHD) (ICD10 code T86.0 or D89.8) (SNOMED Code: SCTID: 234646005)
 
Answer To Question 1:
鈥� Myelofibrosis (ICD10 code D47.4) - less than 5

鈥� Polycythaemia Vera (ICD10 code D45) - less than 5

鈥� Graft vs Host Disease (GvHD) (ICD10 code T86.0 or D89.8) (SNOMED Code: SCTID: 234646005) - 0 (zero)
 
Question Number 2:
How many patients were initiated with the following regimens for any condition in the past 6 months? (Patients are classed as initiated if they have not received any of the above treatments in the previous 6 months)

鈥� Momelotinib

鈥� Fedratinib
 
Answer To Question 2:
鈥� Momelotinib - less than 5

鈥� Fedratinib - 0 (zero)
 
Question Number 3:
How many patients were treated in the past 6 months for Polycythaemia Vera (ICD10 code D45) with?

鈥� Hydroxycarbamide

鈥� Interferon therapy
 
Answer To Question 3:
鈥� Hydroxycarbamide - 13

鈥� Interferon therapy - 7
 
Question Number 4:
Of the myelofibrosis (ICD10 D47.4) patients receiving the following treatments in the past 6 months, please indicate how many were receiving their first systemic therapy

(First systemic therapy = patient has not previously received any drug treatment for myelofibrosis, including hydroxycarbamide, interferon therapy, JAK inhibitors, or other systemic therapy. Excludes a watch and wait approach.)

See attached
 
Answer To Question 4:
Please see attached

To accompany this answer to question 4 please also see the documents listed below:

 FOI 9563 - Q4.pdf
Please see Attachments:
 
To return to the list of all the FOI requests please click here

Our staff at SA国际传媒 Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Person Centred & Safe

Professional

Responsive

Friendly

Progressive

SA国际传媒, SA国际传媒 Hospital, Odstock Road, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2026 SA国际传媒
Trust Values